• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种最小二乘法拟合程序,用于高效地对血脑屏障内皮细胞的被动转运进行临床前分级。

A least-squares-fitting procedure for an efficient preclinical ranking of passive transport across the blood-brain barrier endothelium.

机构信息

Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA.

Department of Chemistry, Aarhus University, Langelandsgade 140, 8000, Aarhus C, Denmark.

出版信息

J Comput Aided Mol Des. 2023 Nov;37(11):537-549. doi: 10.1007/s10822-023-00525-1. Epub 2023 Aug 12.

DOI:10.1007/s10822-023-00525-1
PMID:37573260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10505096/
Abstract

The treatment of various disorders of the central nervous system (CNS) is often impeded by the limited brain exposure of drugs, which is regulated by the human blood-brain barrier (BBB). The screening of lead compounds for CNS penetration is challenging due to the biochemical complexity of the BBB, while experimental determination of permeability is not feasible for all types of compounds. Here we present a novel method for rapid preclinical screening of libraries of compounds by utilizing advancements in computing hardware, with its foundation in transition-based counting of the flux. This method has been experimentally validated for in vitro permeabilities and provides atomic-level insights into transport mechanisms. Our approach only requires a single high-temperature simulation to rank a compound relative to a library, with a typical simulation time converging within 24 to 72 h. The method offers unbiased thermodynamic and kinetic information to interpret the passive transport of small-molecule drugs across the BBB.

摘要

中枢神经系统(CNS)各种疾病的治疗常常受到血脑屏障(BBB)限制,药物在大脑中的暴露量有限。由于 BBB 的生化复杂性,先导化合物对 CNS 穿透性的筛选具有挑战性,而对于所有类型的化合物,实验确定渗透性都是不可行的。在这里,我们提出了一种利用计算硬件的进步对化合物文库进行快速临床前筛选的新方法,其基础是基于通量的基于转换的计数。该方法已经通过体外渗透性进行了实验验证,并提供了有关运输机制的原子级见解。我们的方法仅需要一次高温模拟即可相对于文库对化合物进行排序,典型的模拟时间在 24 至 72 小时内收敛。该方法提供了无偏的热力学和动力学信息,以解释小分子药物通过 BBB 的被动转运。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/503ab8e3c116/10822_2023_525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/77df69c7a7e9/10822_2023_525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/eb461bd52be9/10822_2023_525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/e2e35478b6a5/10822_2023_525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/2d576807c699/10822_2023_525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/503ab8e3c116/10822_2023_525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/77df69c7a7e9/10822_2023_525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/eb461bd52be9/10822_2023_525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/e2e35478b6a5/10822_2023_525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/2d576807c699/10822_2023_525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/982f/10505096/503ab8e3c116/10822_2023_525_Fig5_HTML.jpg

相似文献

1
A least-squares-fitting procedure for an efficient preclinical ranking of passive transport across the blood-brain barrier endothelium.一种最小二乘法拟合程序,用于高效地对血脑屏障内皮细胞的被动转运进行临床前分级。
J Comput Aided Mol Des. 2023 Nov;37(11):537-549. doi: 10.1007/s10822-023-00525-1. Epub 2023 Aug 12.
2
An experimentally validated approach to calculate the blood-brain barrier permeability of small molecules.一种经实验验证的小分子血脑屏障透过率计算方法。
Sci Rep. 2019 Apr 16;9(1):6117. doi: 10.1038/s41598-019-42272-0.
3
Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.应用体外 PAMPA 技术和计算机模拟计算方法预测新型 CNS 候选药物的血脑屏障通透性。
Eur J Pharm Sci. 2022 Jan 1;168:106056. doi: 10.1016/j.ejps.2021.106056. Epub 2021 Nov 2.
4
A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.一种使用支持向量机预测中药中中枢神经系统活性化合物血脑屏障通透性不同机制的方法。
J Bioinform Comput Biol. 2016 Feb;14(1):1650005. doi: 10.1142/S0219720016500050. Epub 2015 Oct 27.
5
Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.整合计算机模拟和体外实验方法以预测药物进入中枢神经系统的可及性
Mol Pharm. 2016 May 2;13(5):1540-50. doi: 10.1021/acs.molpharmaceut.6b00031. Epub 2016 Apr 4.
6
In Vitro-In Vivo Correlation of Blood-Brain Barrier Permeability of Drugs: A Feasibility Study Towards Development of Prediction Methods for Brain Drug Concentration in Humans.药物血脑屏障透过率的体外-体内相关性:建立人脑药物浓度预测方法的可行性研究。
Pharm Res. 2022 Jul;39(7):1575-1586. doi: 10.1007/s11095-022-03189-y. Epub 2022 Mar 14.
7
Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.抗胆碱能药物治疗膀胱过度活动症的血脑屏障渗透和外排排除。
Drugs Aging. 2012 Apr 1;29(4):259-73. doi: 10.2165/11597530-000000000-00000.
8
Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration.采用临床正电子发射断层扫描示踪剂对体外基于细胞的人血脑屏障模型进行验证,以预测体内人脑穿透性。
Mol Pharm. 2010 Oct 4;7(5):1805-15. doi: 10.1021/mp1002366. Epub 2010 Sep 15.
9
Explaining Blood-Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms.综合分析不同转运机制解释小分子的血脑屏障通透性。
J Med Chem. 2023 Jun 8;66(11):7253-7267. doi: 10.1021/acs.jmedchem.2c01824. Epub 2023 May 22.
10
Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.在血脑屏障体外模型中模拟脑组织结合,说明了评估脑穿透率的体外和体内方法之间的差异。
Eur J Pharm Biopharm. 2018 Jun;127:453-461. doi: 10.1016/j.ejpb.2018.03.007. Epub 2018 Mar 28.

引用本文的文献

1
Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.用2-羟基二氢吡啶清除丙烯醛可在糖尿病视网膜病变大鼠模型中维持神经血管完整性。
Diabetologia. 2025 Aug 15. doi: 10.1007/s00125-025-06515-2.
2
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting.纳米载体用于鼻脑靶向给药的创新与最新进展综述
Des Monomers Polym. 2025 Feb 10;28(1):7-29. doi: 10.1080/15685551.2025.2464132. eCollection 2025.
3
Permeability Benchmarking: Guidelines for Comparing , , and Measurements.

本文引用的文献

1
Transport of small molecules through the blood-brain barrier: biology and methodology.小分子通过血脑屏障的转运:生物学与方法学
Adv Drug Deliv Rev. 1995 Jul;15(1-3):5-36.
2
Atomistic Model of Solute Transport across the Blood-Brain Barrier.溶质跨血脑屏障转运的原子模型。
ACS Omega. 2021 Dec 29;7(1):1100-1112. doi: 10.1021/acsomega.1c05679. eCollection 2022 Jan 11.
3
Effects of lipid heterogeneity on model human brain lipid membranes.脂质异质性对模型人脑脂质膜的影响。
渗透率基准测试:比较、和测量的指南。 (注:原文中“,, and ”部分内容缺失,翻译只能按现有内容进行)
J Chem Inf Model. 2025 Feb 10;65(3):1067-1084. doi: 10.1021/acs.jcim.4c01815. Epub 2025 Jan 17.
4
Enhanced motivated behavior mediated by pharmacological targeting of the FGF14/Na1.6 complex in nucleus accumbens neurons.通过对伏隔核神经元中FGF14/Na1.6复合物进行药理学靶向介导的增强的动机行为。
Nat Commun. 2025 Jan 2;16(1):110. doi: 10.1038/s41467-024-55554-7.
5
Modeling Substrate Entry into the P-Glycoprotein Efflux Pump at the Blood-Brain Barrier.模拟血脑屏障中 P-糖蛋白外排泵的底物进入。
J Med Chem. 2023 Dec 28;66(24):16615-16627. doi: 10.1021/acs.jmedchem.3c01069. Epub 2023 Dec 14.
Soft Matter. 2021 Jan 7;17(1):126-135. doi: 10.1039/d0sm01766c. Epub 2020 Nov 6.
4
Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning.利用体外血脑屏障模型和药物重定位进行中枢神经系统疾病的药物研发。
Curr Pharm Des. 2020;26(13):1466-1485. doi: 10.2174/1381612826666200224112534.
5
SciPy 1.0: fundamental algorithms for scientific computing in Python.SciPy 1.0:Python 中的科学计算基础算法。
Nat Methods. 2020 Mar;17(3):261-272. doi: 10.1038/s41592-019-0686-2. Epub 2020 Feb 3.
6
Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression.血液-脑屏障的分子适应促进压力适应与抑郁抵抗。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3326-3336. doi: 10.1073/pnas.1914655117. Epub 2020 Jan 23.
7
Alzheimer's disease: future drug development and the blood-brain barrier.阿尔茨海默病:未来的药物研发与血脑屏障
Expert Opin Investig Drugs. 2019 Jul;28(7):569-572. doi: 10.1080/13543784.2019.1627325. Epub 2019 Jun 4.
8
An experimentally validated approach to calculate the blood-brain barrier permeability of small molecules.一种经实验验证的小分子血脑屏障透过率计算方法。
Sci Rep. 2019 Apr 16;9(1):6117. doi: 10.1038/s41598-019-42272-0.
9
Molecular Dynamics Simulations of Membrane Permeability.膜通透性的分子动力学模拟。
Chem Rev. 2019 May 8;119(9):5954-5997. doi: 10.1021/acs.chemrev.8b00486. Epub 2019 Feb 12.
10
Molecular Dynamics Simulation for All.分子动力学模拟概览。
Neuron. 2018 Sep 19;99(6):1129-1143. doi: 10.1016/j.neuron.2018.08.011.